Search Results - O. V. Filon
- Showing 1 - 5 results of 5
-
1
DEVELOPMENT AND VALIDATION OF A METHOD FOR DETERMINING NEUTRALIZING ANTIBODIES TO PEMBROLIZUMAB IN HUMAN SERUM BASED ON INHIBITION OF BINDING OF PEMBROLIZUMAB TO ITS PD-1 TARGET BY... by A. M. Kudryashova, D. Yu. Grebenkin, M. Yu. Samsonov, O. V. Filon, V. A. Razzhivina, M. G. Chernobrovkin, O. V. Borisova
Published 2019-08-01
Article -
2
-
3
CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 by E. V. Tavlueva, E. V. Zernova, M. P. Kutepova, N. E. Kostina, V. S. Lesina, D. R. Mould, K. Ito, A. V. Zinchenko, A. N. Dolgorukova, M. V. Nikolskaya, M. S. Lemak, O. V. Filon, M. Yu. Samsonov
Published 2022-12-01
Article -
4
Bioequivalence study of generic nirmatrelvir in healthy volunteers by R. A. Oseshnyuk, A. G. Nikiforova, A. Yu. Boroduleva, P. D. Sobolev, S. A. Lesnichuk, B. B. Garyaev, A. A. Abramova, V. G. Mozgovaya, O. V. Filon, A. V. Zinkovskaya, A. N. Dolgorukova, E. K. Khanonina, V. G. Ignatiev, M. Yu. Samsonov
Published 2023-05-01
Article -
5
Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19 by E. V. Shipaeva, O. V. Filon, A. V. Zintchenko, G. A. Shipunov, A. A. Dmitrieva, M. S. Lemak, S. A. Grishin, E. I. Trofimets, K. L. Kryshen, L. I. Kozlovskaya, A. S. Lunin, V. D. Apolokhov, S. F. Barbashov, Ya. V. Lavrovsky, M. Yu. Samsonov
Published 2022-12-01
Article